Browse our resources

Biometric risk correlation after population events needs a clear data-ownership and escalation model. Here is how reinsurers should structure ongoing monitoring for this exposure.

2026-09-08

Biometric risk correlation after population events is the diagnosis problem growing quietly behind biometric-informed reinsurance portfolios. Here is why individually strong risk signals can become correlated portfolio risk overnight.

2026-09-08

Biometric risk correlation after population events does not erode margin gradually the way isolated mispricing does. Here is why it hits a reinsurance portfolio all at once, and how to size that exposure.

2026-09-08

Biometric risk correlation after population events raises a direct balance-sheet question boards are not yet asking. Here is how much exposure it can create, and how to size it.

2026-09-08

Biometric risk correlation after population events raises questions most vendor pricing models have never had to answer. Here is the executive decision framework a Chief Actuary should apply.

2026-09-08

Claims leakage in high-volume health portfolios stops being a recurring surprise once it becomes a measured, repeatable process with clear metrics, sampling standards, and accountability.

2026-09-08

Claims leakage in high-volume health portfolios is not just a primary insurer problem, it directly shapes the loss experience, pricing, and treaty terms reinsurers depend on.

2026-09-08

Boards overseeing life and health reinsurers should not tolerate claims leakage in high-volume health portfolios without specific, quantified evidence of detection and remediation from management.

2026-09-08

Claims leakage in high-volume health portfolios needs a specific executive decision framework across underwriting, claims, and finance, not a single department quietly trying to fix it alone.

2026-09-08

Claims leakage in high-volume health portfolios can quietly turn a fast-growing, seemingly profitable book into a margin problem, since growth simply scales the leakage along with the premium.

2026-09-08

A practical operating playbook for closing the cloud concentration gap before the next renewal, covering submission changes, technographic scanning, treaty wording, and ownership.

2026-09-08

Cloud concentration beyond named providers hides aggregation risk inside shared backend services that policy schedules never list, leaving cyber and technology reinsurers exposed to losses they never priced.

2026-09-08

Board risk committees need a specific set of questions to test whether management actually has visibility into cloud concentration beyond named providers before it becomes a correlated loss event.

2026-09-08

Cloud concentration beyond named providers forces reinsurance CEOs and CUOs to make explicit decisions about visibility investment, capacity deployment, and growth trade-offs before the next shared-infrastructure event.

2026-09-08

Cloud concentration beyond named providers turns one shared outage into many simultaneous claims, quietly eroding margin and distorting capital allocation across cyber and technology reinsurance books.

2026-09-08

Solving cyber event definitions across multiple treaties requires an operating control, not another one-off legal review after a loss.

2026-09-08

Cyber event definitions across multiple treaties often diverge just enough to distort aggregation, allocation, and underperformance analysis for reinsurers.

2026-09-08

Boards need a clear answer to what would break first if cyber event definitions across multiple treaties stayed ambiguous through the next systemic event.

2026-09-08